From TADS and SOFTADS to TORDIA and Beyond: What’s New in the Treatment of Adolescent Depression?
- Zheya Jenny YuAffiliated withHall-Mercer MH/MR Center, Pennsylvania Hospital, University of Pennsylvania Health System
- , Christopher J. KratochvilAffiliated withUniversity of Nebraska Medical Center Email author
- , Ronald A. WellerAffiliated withDepartment of Psychiatry, University of Pennsylvania
- , Mira MoorevilleAffiliated withUniversity of Michigan
- , Elizabeth B. WellerAffiliated withThe Children’s Hospital of Philadelphia, University of Pennsylvania
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Major depressive disorder in adolescents is associated with significant morbidity and mortality. Major advances have been made in recent years in the treatment of adolescent depression, with promising outcomes. However, limitations of currently available treatments have prompted attempts to better understand pediatric depression from a broader perspective and to develop more effective treatment strategies in the future.
KeywordsAdolescent Depression Pharmacotherapy Cognitive-behavioral therapy
- From TADS and SOFTADS to TORDIA and Beyond: What’s New in the Treatment of Adolescent Depression?
Current Psychiatry Reports
Volume 12, Issue 2 , pp 88-95
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Cognitive-behavioral therapy
- Industry Sectors
- Author Affiliations
- 1. Hall-Mercer MH/MR Center, Pennsylvania Hospital, University of Pennsylvania Health System, 245 South 8th Street, Philadelphia, PA, 19107, USA
- 2. University of Nebraska Medical Center, 985581 Nebraska Medical Center, Omaha, NE, 68198-5581, USA
- 3. Department of Psychiatry, University of Pennsylvania, 3600 Market Street, 7th Floor, Philadelphia, PA, 19104, USA
- 4. University of Michigan, Ann Arbor, MI, USA
- 5. The Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA